InsiderClue
Stocks · Technology · Laboratory Analytical Instruments

Avantor, Inc.

AVTR Clue Score37
United States Fiscal year ends December CIK 0001722482 Results filed 28 Oct 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

35
Insider
Date
Role
Action
Shares
Price
Amount
Gerard Brophy
3 Jan 2022
EVP, Biopharma Production
Sold after exercise
59,418
$40.77
$2.42M
Christophe Couturier
27 Dec 2021
EVP, Amea
Sold after exercise
10,184
$41.63
$423.96K
Christophe Couturier
22 Dec 2021
EVP, Amea
Sold after exercise
28,125
$41.53
$1.17M
Christophe Couturier
21 Dec 2021
EVP, Amea
Sold after exercise
38,309
$41.00
$1.57M
Christophe Couturier
9 Dec 2021
EVP, Amea
Sold after exercise
7,859
$40.24
$316.25K
Christophe Couturier
8 Dec 2021
EVP, Amea
Sold after exercise
5,828
$40.00
$233.12K
Frederic Vanderhaegen
12 Nov 2021
EVP, Europe
Sold after exercise
80,000
$38.25
$3.06M
Gerard Brophy
30 Jul 2021
EVP, Biopharma Production
Sold after exercise
81,125
$37.24
$3.02M
Michael Stubblefield
10 Jun 2021
President and CEO
Sold after exercise
57,375
$32.48
$1.86M
Michael Stubblefield
10 Jun 2021
President and CEO
Sold after exercise
42,512
$32.48
$1.38M
Michael Stubblefield
9 Jun 2021
President and CEO
Sold after exercise
235,170
$32.03
$7.53M
Michael Stubblefield
8 Jun 2021
President and CEO
Sold after exercise
152,643
$32.04
$4.89M
Devashish Ohri
27 May 2021
EVP, Imea
Sold after exercise
100,000
$31.99
$3.20M
Devashish Ohri
26 May 2021
EVP, Imea
Sold after exercise
15,000
$31.87
$478.05K
Devashish Ohri
24 May 2021
EVP, Imea
Sold after exercise
9,124
$31.75
$289.69K
Devashish Ohri
30 Apr 2021
EVP, Imea
Sold after exercise
53,649
$32.58
$1.75M
Justin Miller
12 Apr 2021
EVP & General Counsel
Sold after exercise
100,000
$33.21
$3.32M
Justin Miller
12 Apr 2021
EVP & General Counsel
Sold after exercise
2,895
$31.75
$91.92K
Devashish Ohri
12 Apr 2021
EVP, Imea
Sold after exercise
100,160
$32.37
$3.24M
Gerard Brophy
22 Feb 2021
EVP, Biopharma Production
Sold after exercise
19,769
$28.62
$565.79K
Michael Wondrasch
5 Feb 2021
EVP & CIO
Sold after exercise
40,000
$29.77
$1.19M
Michael Wondrasch
5 Feb 2021
EVP & CIO
Sold after exercise
9,468
$29.77
$281.86K
Gerard Brophy
11 Jan 2021
EVP, Biopharma Production
Sold after exercise
162,248
$30.04
$4.87M
Gerard Brophy
11 Jan 2021
EVP, Biopharma Production
Sold after exercise
216,332
$30.08
$6.51M
Gerard Brophy
4 Jan 2021
EVP, Biopharma Production
Sold after exercise
59,418
$27.84
$1.65M
Michael Stubblefield
7 Dec 2020
President and CEO
Sold after exercise
98,452
$27.45
$2.70M
Michael Stubblefield
4 Dec 2020
President and CEO
Sold after exercise
412,188
$27.08
$11.16M
Devashish Ohri
5 Oct 2020
EVP, Imea
Sold after exercise
50,000
$23.34
$1.17M
Devashish Ohri
5 Oct 2020
EVP, Imea
Sold after exercise
35,000
$23.47
$821.45K
Devashish Ohri
5 Oct 2020
EVP, Imea
Sold after exercise
18,440
$23.53
$433.89K
Devashish Ohri
16 Sep 2020
EVP, Imea
Sold after exercise
35,000
$23.02
$805.70K
Devashish Ohri
30 Jul 2020
EVP, Imea
Sold after exercise
35,000
$21.37
$747.95K
Devashish Ohri
29 May 2020
EVP, Imea
Sold after exercise
35,000
$19.07
$667.45K
Devashish Ohri
29 May 2020
EVP, Imea
Sold after exercise
30,000
$18.57
$557.10K
Devashish Ohri
18 Feb 2020
EVP, Imea
Sold after exercise
20,000
$17.54
$350.80K
Show all 221 transactions →

What was left out

Form 4 filings counted 437
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 8
Sales on a Rule 10b5-1 plan 9
Sales straight out of an exercise 35
Sales at will 106
Transactions with no price 0
Shares from compensation/vesting 259,396,189
Sales filed before the plan box existed 100
History held since 23 May 2019